Inotek Pharmaceuticals Garners $5,600,000 New Round

  • Feed Type
  • Date
    7/19/2011
  • Company Name
    Inotek Pharmaceuticals
  • Mailing Address
    33 Hayden Avenue 2nd Floor Lexington, MA 02421
  • Company Description
    Inotek Pharmaceuticals Corporation is a private, high-growth, development-stage pharmaceutical company founded in 1996. The Company has leveraged its small molecule chemistry expertise to discover and develop a deep pipeline of therapeutics targeting cell death, DNA repair and inflammatory pathways. Inotek’s lead program is focused on blocking the nuclear DNA repair enzyme, poly (ADP-ribose) polymerase (or PARP), that has broad application in a variety of unmet medical needs.
  • Website
    http://www.inotekcorp.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy